TerminatedPhase 3NCT02947581
Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)
Studying Cysticercosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidad Peruana Cayetano Heredia
- Principal Investigator
- Hector H. Garcia Lescano, Ph.DUniversidad Peruana Cayetano Heredia
- Intervention
- Albendazole and praziquantel(drug)
- Enrollment
- 107 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2016 – 2021
Study locations (2)
- Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru
- Hospital Nacional Cayetano Heredia, Lima, Peru
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02947581 on ClinicalTrials.govOther trials for Cysticercosis
Additional recruiting or active studies for the same condition.